UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported) May 30, 2013

 

 

THE MACERICH COMPANY

(Exact Name of Registrant as Specified in Charter)

 

MARYLAND

 

1-12504

 

95-4448705

(State or Other Jurisdiction of
Incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

401 Wilshire Boulevard, Suite 700, Santa Monica, California 90401

         (Address of Principal Executive Offices)                   (Zip Code)

 

Registrant’s telephone number, including area code  (310) 394-6000

 

N/A

(Former Name or Former Address, if Changed Since Last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

ITEM 5.07.   Submission of Matters to a Vote of Security Holders.

 

 

(a)  The Macerich Company (the “Company”) held its Annual Meeting of Stockholders on May 30, 2013 (the “Annual Meeting”).

 

(b)  At the Annual Meeting, the Company’s stockholders (i) elected the ten nominees listed below to serve as directors for a term expiring at the next annual meeting of stockholders and until their respective successors are duly elected and qualified, (ii) ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013, (iii) approved the compensation of the Company’s named executive officers and (iv) approved the amendment and restatement of the Company’s Employee Stock Purchase Plan.

 

Item 1:  The election of ten directors for a term expiring at the next annual meeting of stockholders and until their respective successors are duly elected and qualified.

 

 

       For       

      Against      

  Abstensions  

Broker Non-
       Votes       

Douglas D. Abbey

121,490,205

232,540

48,974

4,712,078

Dana K. Anderson

116,845,652

4,877,104

48,963

4,712,078

Arthur M. Coppola

117,505,899

3,992,574

273,246

4,712,078

Edward C. Coppola

116,846,744

4,876,835

48,140

4,712,078

Fred S. Hubbell

120,979,426

743,280

49,013

4,712,078

Diana M. Laing

121,451,695

272,050

47,974

4,712,078

Stanley A. Moore

121,048,589

674,719

48,411

4,712,078

Mason G. Ross

121,491,455

232,092

48,172

4,712,078

Dr. William P. Sexton

121,198,961

522,047

50,711

4,712,078

Andrea M. Stephen

121,494,699

229,402

47,618

4,712,078

 

 

Item 2:            The ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013.

 

 

         For         

        Against        

  Abstensions  

 

 

126,396,725

25,799

61,273

 

 

There were no broker non-votes for Item 2.

 

2



 

Item 3:            Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers.

 

 

         For        

        Against        

  Abstensions  

Broker Non-
     Votes     

 

119,864,584

1,627,155

279,980

4,712,078

 

 

 

Item 4:            Approval of the amendment and restatement of the Company’s Employee Stock Purchase Plan.

 

 

         For        

        Against        

  Abstensions  

Broker Non-
     Votes     

 

121,486,766

229,680

55,273

4,712,078

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, The Macerich Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

THE MACERICH COMPANY

 

 

 

By: THOMAS J. LEANSE

 

 

 

 

June 3, 2013

 

/s/ Thomas J. Leanse

 

Date

Senior Executive Vice President,

 

Chief Legal Officer and Secretary

 

4